Paolo Rigano

Palermo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

The use of hydroxyurea in the real life of MIOT network: an observational study.

The use of hydroxyurea in the real life of MIOT network: an observational study.

Journal: Expert opinion on drug safety

Published: April 18, 2022

Morbidity and mortality of sickle cell disease patients is unaffected by splenectomy: evidence from three decades of follow-up in a high-income setting.

Morbidity and mortality of sickle cell disease patients is unaffected by splenectomy: evidence from three decades of follow-up in a high-income setting.

Journal: Haematologica

Published: February 10, 2022

Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy.

Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy.

Journal: Frontiers in medicine

Published: December 09, 2021

Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm.

Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm.

Journal: HemaSphere

Published: November 17, 2020

Long-term sequential deferiprone and deferasirox therapy in transfusion-dependent thalassaemia patients: a prospective clinical trial.

Long-term sequential deferiprone and deferasirox therapy in transfusion-dependent thalassaemia patients: a prospective clinical trial.

Journal: British journal of haematology

Published: July 26, 2019

Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.

Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.

Journal: Orphanet journal of rare diseases

Published: March 20, 2019

Access to emergency departments for acute events and identification of sickle cell disease in refugees.

Access to emergency departments for acute events and identification of sickle cell disease in refugees.

Journal: Blood

Published: February 13, 2019

Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.

Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.

Journal: International journal of molecular sciences

Published: January 05, 2018

Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies.

Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies.

Journal: American journal of hematology

Published: July 27, 2017

Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: Results of a National Multicenter survey.

Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: Results of a National Multicenter survey.

Journal: Pediatric blood & cancer

Published: June 08, 2017

Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent.

Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent.

Journal: Blood cells, molecules & diseases

Published: May 30, 2017

Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.

Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.

Journal: Hemoglobin

Published: May 29, 2015

Showing 1-12 of 20

Last Updated: 09/26/2026